2m 2m 2m 2m 2m 2m 2m
ATYR PHARMA (ATYR)
NASDAQ
$0.29-$0.005 (-1.73%)
Price as of Oct 02, 2026 6:14 PM EDT- $28.8MMarket Cap
- -58.57%1-Year Change
- BiotechnologyIndustry
ATYR PHARMA (ATYR)
$0.29-$0.005 (-1.73%)
Top Holders
Institutional
Mutual Funds
No data found
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
Federated Hermes Equity Funds | 8.60% | 8.4M | -2.0M (-23.29%) | Jul 31, 2026 |
FIDELITY MT VERNON STREET TRUST | 4.30% | 4.2M | -2.6M (-60.96%) | May 31, 2026 |
VANGUARD INDEX FUNDS | 3.78% | 3.7M | +48,153 (+1.30%) | Jun 30, 2026 |
SPDR SERIES TRUST | 2.23% | 2.2M | 0 (0.00%) | Jul 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 1.79% | 1.8M | 0 (0.00%) | Jul 31, 2026 |
VANGUARD SCOTTSDALE FUNDS | 0.60% | 586,631 | +15,775 (+2.69%) | May 31, 2026 |
Invesco Exchange-Traded Fund Trust II | 0.55% | 539,321 | 0 (0.00%) | Jul 31, 2026 |
Current Ownership Distribution
- Mutual Funds101.3M (95.94%)
- Insiders4.3M (4.06%)
- Institutions0 (0.00%)
- Other0 (0.00%)
Insider Transactions
- 4.06% (4.3M)Current InsiderOwnership (%, shares)
- 1Number of InsiderBuying (last 12 months)
- $1.4MAmount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $212,333.95Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Yaras Brandon Chief Financial Officer | Award | Oct 01, 2026 | $0.00 | 410,000 | $0.00 | 410,000 |
Broadfoot Jill Marie Chief Financial Officer | Sell | Feb 04, 2026 | $1,520.61 | 1,558 | $0.98 | 37,296 |
Krueger Nancy General Counsel | Sell | Feb 04, 2026 | $1,091.28 | 1,118 | $0.98 | 33,124 |
Shukla Sanjay President and CEO | Sell | Feb 04, 2026 | $3,655.12 | 3,745 | $0.98 | 153,553 |
Krueger Nancy General Counsel | Exempt | Feb 03, 2026 | $0.00 | 2,687 | $0.00 | 0 |
Shukla Sanjay President and CEO | Exempt | Feb 03, 2026 | $0.00 | 10,375 | $0.00 | 0 |
Krueger Nancy General Counsel | Exempt | Feb 03, 2026 | $0.00 | 2,687 | $0.00 | 34,242 |
Shukla Sanjay President and CEO | Exempt | Feb 03, 2026 | $0.00 | 10,375 | $0.00 | 157,298 |
Broadfoot Jill Marie Chief Financial Officer | Exempt | Feb 03, 2026 | $0.00 | 3,750 | $0.00 | 0 |
Broadfoot Jill Marie Chief Financial Officer | Exempt | Feb 03, 2026 | $0.00 | 3,750 | $0.00 | 38,854 |
Shukla Sanjay President and CEO | Award | Jan 09, 2026 | $0.00 | 1.5M | $0.00 | 1.5M |
Krueger Nancy General Counsel | Award | Jan 09, 2026 | $0.00 | 412,500 | $0.00 | 412,500 |
SCHIMMEL PAUL | Buy | Oct 09, 2025 | $299,364.26 | 317,999 | $0.94 | 1.4M |
SCHIMMEL PAUL | Buy | Oct 08, 2025 | $612,436.90 | 682,001 | $0.90 | 1.1M |
BENEVICH ERIC | Award | May 01, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
Gross Jane A | Award | May 01, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
Zaknoen Sara | Award | May 01, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
Coughlin Timothy P | Award | May 01, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
Lucas Svetlana | Award | May 01, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
SCHIMMEL PAUL | Award | May 01, 2025 | $0.00 | 50,000 | $0.00 | 50,000 |
Gross Jane A | Buy | Mar 17, 2025 | $15,000.00 | 3,750 | $4.00 | 9,750 |
Krueger Nancy General Counsel | Sell | Feb 04, 2025 | $3,398.22 | 899 | $3.78 | 26,555 |
Broadfoot Jill Marie Chief Financial Officer | Sell | Feb 04, 2025 | $4,740.12 | 1,254 | $3.78 | 31,763 |
Shukla Sanjay President and CEO | Exempt | Feb 03, 2025 | $0.00 | 10,375 | $0.00 | 10,375 |
Broadfoot Jill Marie Chief Financial Officer | Exempt | Feb 03, 2025 | $0.00 | 3,750 | $0.00 | 3,750 |
Krueger Nancy General Counsel | Exempt | Feb 03, 2025 | $0.00 | 2,687 | $0.00 | 2,687 |
Broadfoot Jill Marie Chief Financial Officer | Exempt | Feb 03, 2025 | $0.00 | 3,750 | $0.00 | 33,017 |
Shukla Sanjay President and CEO | Exempt | Feb 03, 2025 | $0.00 | 10,375 | $0.00 | 146,923 |
Krueger Nancy General Counsel | Exempt | Feb 03, 2025 | $0.00 | 2,687 | $0.00 | 27,454 |
Krueger Nancy General Counsel | Award | Jan 08, 2025 | $0.00 | 275,000 | $0.00 | 275,000 |